Development and implementation of a potential coronavirus disease 2019 (COVID-19) vaccine: A systematic review and meta-analysis of vaccine clinical trials.

Nepal J Epidemiol · 2021 · PMC8033643 · PMID 33868742

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

might not be significantno p-value reported

A rough guide for the interpretation of I 2 test is as follows: 0-25% (might not be significant); 25-50% (may represent moderate heterogeneity); 50-75% (may represent substantial heterogeneity) and >75% (considerable heterogeneity).

also in 673 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.